RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Earnings per share

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2024-17.5-28.76%
Dec 31, 2023-24.6-12.88%
Dec 31, 2022-28.3-23.08%
Dec 31, 2021-36.7+1.89%
Dec 31, 2020-36.1-19.17%
Dec 31, 2019-44.6-22.09%
Dec 31, 2018-57.3+71.03%
Dec 31, 2017-33.5-49.20%
Dec 31, 2016-65.9+13.07%
Dec 31, 2015-58.3+34.15%
Dec 31, 2014-43.4+11.07%
Mar 31, 2014-39.1+53.53%
Mar 31, 2013-25.5+740.92%
Mar 31, 2012-3-80.88%
Mar 31, 2011-15.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)